S339-1022 Screening compound: 3-(3-methoxyphenyl)-1-(4-{[3-(2-pyrazinyl)-1,2,4-oxadiazol-5-yl]methyl}piperidino)-1-propanone

S339-1022 Screening compound: 3-(3-methoxyphenyl)-1-(4-{[3-(2-pyrazinyl)-1,2,4-oxadiazol-5-yl]methyl}piperidino)-1-propanone
S339-1022 Screening compound: 3-(3-methoxyphenyl)-1-(4-{[3-(2-pyrazinyl)-1,2,4-oxadiazol-5-yl]methyl}piperidino)-1-propanone alternative view

Chemical Structure Depiction of ChemDiv screening compound S339-1022
3-(3-methoxyphenyl)-1-(4-{[3-(2-pyrazinyl)-1,2,4-oxadiazol-5-yl]methyl}piperidino)-1-propanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S339-1022

Molecular Formula

C22H25N5O3 (C22 H25 N5 O3)

Compound Name

3-(3-methoxyphenyl)-1-(4-{[3-(2-pyrazinyl)-1,2,4-oxadiazol-5-yl]methyl}piperidino)-1-propanone

IUPAC name

3-(3-methoxyphenyl)-1-(4-{[3-(pyrazin-2-yl)-124-oxadiazol-5-yl]methyl}piperidin-1-yl)propan-1-one

SMILES

COc1cccc(CCC(N2CCC(Cc3nc(-c4nccnc4)no3)CC2)=O)c1

InChI

InChI=1S/C22H25N5O3/c1-29-18-4-2-3-16(13-18)5-6-21(28)27-11-7-17(8-12-27)14-20-25-22(26-30-20)19-15-23-9-10-24-19/h2-4,9-10,13,15,17H,5-8,11-12,14H2,1H3

InChI Key

VBZYGUWFIDPLTC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD28998283

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

407.47

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.867

Distribution Coefficient, logD

2.867

Water Solubility, LogSw

-2.90

Polar Surface Area

73.540

Acid Dissociation Constant (pKa)

23.24

Base Dissociation Constant (pKb)

4.05

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.91

S339-1022 in Drug Discovery

Included in Screening Libraries

Ligand-Gated Ion Channels Library (3887 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Indoleamine 2,3-dioxygenase 1 Focused Library (5816 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Eye
  • Cancer
  • Digestive system
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Immune system
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Ion Channels
  • Others
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S339-1022 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S339-1022?
Check Price and Availability of S339-1022, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S339-1022 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S339-1022
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S339-1022
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S339-1022 available by request